Implementation of a System-level Tobacco Treatment Intervention
NCT ID: NCT02816697
Last Updated: 2026-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
263 participants
INTERVENTIONAL
2016-06-30
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient Navigation and Financial Incentives to Promote Smoking Cessation
NCT02351609
Integrating Tobacco Treatment Into Cancer Care: A Randomized Controlled Comparative Effectiveness Trial
NCT01871506
Tobacco Treatment Outreach to Reduce Disparities for Primary Care Populations
NCT01156610
Evidence-Based Tobacco Cessation Strategies in Patients With Cancer
NCT02211196
Clinical Effort Against Secondhand Smoke (CEASE) Program or Standard Care in Helping Parents Stop Smoking
NCT00664261
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Adaption of CEASE will entail exit interviews with patients and individual interviews with clinical staff to identify and address facilitators and barriers to the implementation process.
* Effectiveness of CEASE will be measured through questionnaires \& biochemical verification of smoking status using a pre-test/post-test study design before (usual care)and after implementation (CEASE)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cease-Aim 1
* Cease Implementation
* 100 Patients after CEASE Implementation
* Exit Interview and Tobacco Use Survey
CEASE
* Clinical and Community Effort Against Secondhand Smoke Exposure (CEASE)
* CEASE is a system-level intervention that integrates tobacco-use screening, cessation assistance, and referral to outside services into routine visits
Pre Cease Implementation Aim 2
50 Current or former smokers (3 months +/-2 month) patients in usual care (before CEASE implementation)
* Tobacco Use Survey (Baseline,1- 6 Months)
* Biochemical verification
Usual Care Tobacco Treatment Services
After Cease Implementation Aim 2
50 Current or former smokers (3 months +/-2 month)
* Tobacco Use Survey (Baseline,1- 6 Months)
* Biochemical verification
CEASE
* Clinical and Community Effort Against Secondhand Smoke Exposure (CEASE)
* CEASE is a system-level intervention that integrates tobacco-use screening, cessation assistance, and referral to outside services into routine visits
Usual Care-Aim 1
Usual Care Tobacco Treatment Services
* 100 patients in usual care
* Exit Interview and Tobacco Use Survey
Usual Care Tobacco Treatment Services
Clinician and Staff Survey
\- Interview clinicians and support staff (40)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CEASE
* Clinical and Community Effort Against Secondhand Smoke Exposure (CEASE)
* CEASE is a system-level intervention that integrates tobacco-use screening, cessation assistance, and referral to outside services into routine visits
Usual Care Tobacco Treatment Services
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have an actual or potential diagnosis of thoracic malignancy
* Able to read and write in English.
* Current or recent former smoker (defined as having smoked within past 6 months)
* Must have an active telephone number.
Exclusion Criteria
* Have any of the below conditions needing immediate medical intervention
* Hypercalcemia causing lethargy and confusion,
* Acute respiratory distress
* Dehydration
* Hypotension
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brigham and Women's Hospital
OTHER
Massachusetts General Hospital
OTHER
Dana-Farber Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mary E. Cooley, Phd
Mary E. Cooley MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mary E Cooley, PhD, RN
Role: PRINCIPAL_INVESTIGATOR
Dana-Farber Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brigham and Women's Hospital
Boston, Massachusetts, United States
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-208
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.